Alice Park of TIME magazine has a lengthy article, The Quest Resumes, about the resurgence of stem-cell scientists and their research. Prominently featured is Harvard's Douglas Melton.
Jared A. Favole and Alicia Mundy of The Wall Street Journal write: FDA Panel May Reccomend High Fence Around Lilly Clot Drug, which the pair says will have ramifications for the multibillion-dollar market. Jonathan D. Rockoff contributed to the story.
Also:
- Federal regulators sue Solvay and generic firms for conspiring to delay cheaper drugs -- (538 words) By Matthew Perrone -- Associated Press
- FDA Questions Effectiveness of Dyax Drug for Rare Disorder -- (502 words) By Jennifer Corbett Dooren -- Dow Jones Newswires
- Democrats rally behind pick for health chief, imperiled by tax disclosure -- (724 words) By Sheryl Gay Stolberg and Robert Pear -- The New York Times
I came to your article from another article and am really interested in this learning about this.I feel strongly about information and love learning more on this.If possible, as you gain expertise, It is extremely helpful for me. would you mind updating your blog with more information?
Posted by: cheap tiffany | 07/14/2011 at 11:02 PM
He was widely known France the 18th century the famous writer dumas pere. in society many ordinary generations, want some small merits, but because felt inferior is often neglected
Posted by: air force one | 08/17/2011 at 12:36 AM
The story is unique
Posted by: tiffany jewelry outlet | 11/04/2011 at 07:34 PM